• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

印度患者炎症性肠病的自我报告治疗依从性。

Self-reported treatment adherence in inflammatory bowel disease in Indian patients.

作者信息

Bhatt Jay, Patil Samir, Joshi Anand, Abraham Philip, Desai Devendra

机构信息

Division of Gastroenterology, P D Hinduja National Hospital and Medical Research Center, Mahim, Mumbai 400 016, India.

出版信息

Indian J Gastroenterol. 2009 Jul-Aug;28(4):143-6. doi: 10.1007/s12664-009-0050-z. Epub 2009 Nov 24.

DOI:10.1007/s12664-009-0050-z
PMID:19937418
Abstract

INTRODUCTION

Non-adherence to medical therapy is emerging as an important determinant of relapse in patients with inflammatory bowel disease (IBD).

AIM

To find the prevalence of and reasons for nonadherence to medical therapy in Indian patients with IBD and its correlation with disease outcome.

METHODS

In this cross-sectional study, we checked for adherence to treatment in 127 patients with IBD (117 ulcerative colitis and 10 Crohn's disease) using a questionnaire that inquired into frequency of missed doses, causes for missed doses, and its relation to relapse of disease.

RESULTS

Of the 127 patients (mean age 42.8 years; 68 women), 103 (81%) were non-adherent to treatment, defined as taking 80% or less of the dose advised. The reasons for non-adherence (not mutually exclusive) were: forgetfulness-98 patients (77%), felt better-18 (14.2 %), high frequency of doses-13 (10.1%), no effect of medications-10 (7.87%), non-availability of medications-3 (2.3%). Non-adherent patients were three times more likely to develop a relapse as compared to those with adherence (OR 3.389, 95% CI 1.29-8.88, p=0.012).

CONCLUSIONS

Over 80% of patients with IBD in this survey were non-adherent to medical treatment; forgetfulness was mentioned as the most common cause. Non-adherent patients were more likely to relapse. Patients need to be educated regarding the need for adherence to treatment in IBD.

摘要

引言

不坚持药物治疗正成为炎症性肠病(IBD)患者复发的一个重要决定因素。

目的

了解印度IBD患者不坚持药物治疗的患病率、原因及其与疾病转归的相关性。

方法

在这项横断面研究中,我们使用一份问卷对127例IBD患者(117例溃疡性结肠炎和10例克罗恩病)的治疗依从性进行了调查,该问卷询问了漏服药物的频率、漏服原因及其与疾病复发的关系。

结果

127例患者(平均年龄42.8岁;68例女性)中,103例(81%)不坚持治疗,定义为服用的剂量为建议剂量的80%或更少。不坚持治疗的原因(并非相互排斥)如下:遗忘——98例患者(77%),感觉好转——18例(14.2%),服药频率高——13例(10.1%),药物无效果——10例(7.87%),药物无法获取——3例(2.3%)。与坚持治疗的患者相比,不坚持治疗的患者复发的可能性高3倍(比值比3.389,95%置信区间1.29 - 8.88,p = 0.012)。

结论

本次调查中超过80%的IBD患者不坚持药物治疗;遗忘被提及为最常见的原因。不坚持治疗的患者更易复发。需要对患者进行关于IBD治疗中坚持治疗必要性的教育。

相似文献

1
Self-reported treatment adherence in inflammatory bowel disease in Indian patients.印度患者炎症性肠病的自我报告治疗依从性。
Indian J Gastroenterol. 2009 Jul-Aug;28(4):143-6. doi: 10.1007/s12664-009-0050-z. Epub 2009 Nov 24.
2
Impact of Demographic, Clinical and Psychosocial Variables on Drug Adherence and Outcomes in Indian Patients With Inflammatory Bowel Disease: Cost is not the Only Factor!人口统计学、临床和心理社会变量对印度炎症性肠病患者药物依从性和结局的影响:费用不是唯一因素!
J Clin Gastroenterol. 2021;55(10):e92-e99. doi: 10.1097/MCG.0000000000001480.
3
The Frequency of Clinic Visits Was Not Associated with Medication Adherence or Outcome in Children with Inflammatory Bowel Diseases.炎症性肠病患儿的就诊频率与药物依从性或结局无关。
Can J Gastroenterol Hepatol. 2018 Feb 25;2018:4687041. doi: 10.1155/2018/4687041. eCollection 2018.
4
[Treatment adherence and use of complementary and alternative medicine in patients with inflammatory bowel disease].炎症性肠病患者的治疗依从性及补充和替代医学的使用情况
Orv Hetil. 2010 Feb 14;151(7):250-8. doi: 10.1556/OH.2010.28805.
5
Complementary and alternative medicine use and its association with medication adherence in inflammatory bowel disease and other gastrointestinal diseases.补充和替代医学的使用及其与炎症性肠病和其他胃肠道疾病药物依从性的关系。
Saudi J Gastroenterol. 2023 Jul-Aug;29(4):233-239. doi: 10.4103/sjg.sjg_468_22.
6
Development of an Inflammatory Bowel Disease-Specific Medication Adherence Instrument and Reasons for Non-adherence.炎症性肠病特异性药物依从性工具的开发及不依从的原因
Dig Dis Sci. 2023 Jan;68(1):58-64. doi: 10.1007/s10620-022-07517-5. Epub 2022 May 3.
7
Socioeconomic and psychological factors associated with nonadherence to treatment in inflammatory bowel disease patients: results of the ISSEO survey.社会经济和心理因素与炎症性肠病患者治疗不依从的关系:ISSEO 调查结果。
Inflamm Bowel Dis. 2011 Jun;17(6):1270-6. doi: 10.1002/ibd.21482. Epub 2010 Oct 25.
8
Inflammatory bowel disease: adherence to immunomodulators in a biological therapy era.炎症性肠病:生物治疗时代免疫调节剂的依从性
Eur J Gastroenterol Hepatol. 2016 Nov;28(11):1313-9. doi: 10.1097/MEG.0000000000000704.
9
Assessing Self-reported Medication Adherence in Inflammatory Bowel Disease: A Comparison of Tools.评估炎症性肠病患者自我报告的药物依从性:工具比较
Inflamm Bowel Dis. 2016 Sep;22(9):2158-64. doi: 10.1097/MIB.0000000000000853.
10
Covert dose reduction is a distinct type of medication non-adherence observed across all care settings in inflammatory bowel disease.隐性剂量减少是在炎症性肠病的所有护理环境中观察到的一种独特的药物不依从类型。
J Crohns Colitis. 2014 Dec;8(12):1723-9. doi: 10.1016/j.crohns.2014.08.013. Epub 2014 Sep 26.

引用本文的文献

1
Optimizing 5-aminosalicylate for moderate ulcerative colitis: expert recommendations from the Asia-Pacific, Middle East, and Africa Inflammatory Bowel Disease Coalition.优化5-氨基水杨酸治疗中度溃疡性结肠炎:亚太、中东和非洲炎症性肠病联盟的专家建议
Intest Res. 2025 Jan;23(1):37-55. doi: 10.5217/ir.2024.00089. Epub 2024 Nov 4.
2
Study of Inflammatory Bowel Disease in Patients Undergoing Colonoscopy at a Tertiary Center of Nepal.尼泊尔一家三级中心接受结肠镜检查患者的炎症性肠病研究
Cureus. 2024 Aug 16;16(8):e67045. doi: 10.7759/cureus.67045. eCollection 2024 Aug.
3
Complementary and alternative medicine use and its association with medication adherence in inflammatory bowel disease and other gastrointestinal diseases.

本文引用的文献

1
Hepatitis C patients' self-reported adherence to treatment with pegylated interferon and ribavirin.丙型肝炎患者自我报告的聚乙二醇干扰素和利巴韦林治疗依从性。
Aliment Pharmacol Ther. 2008 Aug 1;28(3):289-93. doi: 10.1111/j.1365-2036.2008.03718.x.
2
Review article: medication non-adherence in ulcerative colitis--strategies to improve adherence with mesalazine and other maintenance therapies.综述文章:溃疡性结肠炎患者的药物治疗依从性——提高美沙拉嗪及其他维持治疗依从性的策略
Aliment Pharmacol Ther. 2008 Jun;27(12):1157-66. doi: 10.1111/j.1365-2036.2008.03698.x. Epub 2008 Mar 31.
3
[Compliance to drug therapy in inflammatory bowel diseases outpatients from a university hospital].
补充和替代医学的使用及其与炎症性肠病和其他胃肠道疾病药物依从性的关系。
Saudi J Gastroenterol. 2023 Jul-Aug;29(4):233-239. doi: 10.4103/sjg.sjg_468_22.
4
Crohn's disease in low and lower-middle income countries: A scoping review.低收入和中低收入国家的克罗恩病:一项范围综述
World J Gastroenterol. 2020 Nov 21;26(43):6891-6908. doi: 10.3748/wjg.v26.i43.6891.
5
Adherence to Medical Treatment in Inflammatory Bowel Disease Patients from a Referral Center in Bahia-Brazil.巴西巴伊亚州转诊中心炎症性肠病患者的医疗依从性。
Biomed Res Int. 2020 Sep 26;2020:5269493. doi: 10.1155/2020/5269493. eCollection 2020.
6
Colitis and Crohn's Foundation (India) consensus statements on use of 5-aminosalicylic acid in inflammatory bowel disease.印度结肠炎与克罗恩病基金会关于5-氨基水杨酸在炎症性肠病中应用的共识声明
Intest Res. 2020 Oct;18(4):355-378. doi: 10.5217/ir.2019.09176. Epub 2020 Jul 13.
7
Higher education, professional occupation, and upper socioeconomic status are associated with lower adherence to medications in patients with inflammatory bowel disease.高等教育、职业、较高的社会经济地位与炎症性肠病患者较低的药物依从性相关。
JGH Open. 2019 Mar 18;3(4):302-309. doi: 10.1002/jgh3.12160. eCollection 2019 Aug.
8
Determining the degree of adherence to treatment in inflammatory bowel disease patients.确定炎症性肠病患者的治疗依从程度。
Gastroenterol Hepatol Bed Bench. 2018 Winter;11(Suppl 1):S39-S44.
9
Gastroenterology and the provision of care to Panjabi patients in the UK.胃肠病学以及在英国为旁遮普族患者提供护理服务。
Frontline Gastroenterol. 2012 Jul;3(3):191-198. doi: 10.1136/flgastro-2012-100119. Epub 2012 Apr 13.
10
Indian Society of Gastroenterology consensus on ulcerative colitis.印度胃肠病学会关于溃疡性结肠炎的共识
Indian J Gastroenterol. 2012 Dec;31(6):307-23. doi: 10.1007/s12664-012-0259-0. Epub 2012 Oct 25.
[某大学医院炎症性肠病门诊患者的药物治疗依从性]
Arq Gastroenterol. 2007 Oct-Dec;44(4):289-96. doi: 10.1590/s0004-28032007000400003.
4
The challenge of compliance and persistence: focus on ulcerative colitis.依从性和持续性的挑战:聚焦溃疡性结肠炎
J Manag Care Pharm. 2008 Jan;14(1 Suppl A):s2-12; quiz s13-5. doi: 10.18553/jmcp.2008.14.S1-A.1a.
5
Risk factors for non-adherence to medication in inflammatory bowel disease patients.炎症性肠病患者药物治疗不依从的风险因素。
Aliment Pharmacol Ther. 2008 Jan 15;27(2):166-72. doi: 10.1111/j.1365-2036.2007.03555.x. Epub 2007 Oct 20.
6
Predictors of medication adherence in inflammatory bowel disease.炎症性肠病药物依从性的预测因素
Am J Gastroenterol. 2007 Jul;102(7):1417-26. doi: 10.1111/j.1572-0241.2007.01212.x. Epub 2007 Apr 16.
7
Interventions to enhance medication adherence in chronic medical conditions: a systematic review.改善慢性病患者药物依从性的干预措施:一项系统综述。
Arch Intern Med. 2007 Mar 26;167(6):540-50. doi: 10.1001/archinte.167.6.540.
8
A practical perspective on ulcerative colitis: patients' needs from aminosalicylate therapies.溃疡性结肠炎的实用观点:患者对氨基水杨酸疗法的需求
Inflamm Bowel Dis. 2006 Dec;12(12):1107-13. doi: 10.1097/01.mib.0000235831.01682.8d.
9
Relationship of blood pressure control to adherence with antihypertensive monotherapy in 13 managed care organizations.13家管理式医疗组织中血压控制与抗高血压单药治疗依从性的关系
J Manag Care Pharm. 2006 Apr;12(3):239-45. doi: 10.18553/jmcp.2006.12.3.239.
10
Adherence to medication.药物依从性
N Engl J Med. 2005 Aug 4;353(5):487-97. doi: 10.1056/NEJMra050100.